Brind.

Insider sale disclosed in SEC filing involving Kevin Mcculloch.

3 reports, 1 independent Updated Fri 00:00
Still developing Reached 2 outlets in its first 24 hours
Reports
3
Developments
2
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Insider sale disclosed in SEC filing involving Kevin Mcculloch.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Kevin Mcculloch sold Xeris Biopharma shares, disclosed via SEC filing.1 source
  2. Insider sale disclosed in SEC filing involving Kevin Mcculloch.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story